Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
India Issues Travel Advisory as WHO Declares Ebola Outbreak Global Health Emergency
WHO declares Bundibugyo Ebola outbreak a public health emergency of international concern with 204 deaths across DRC and Uganda. India issues travel advisory a…
HighDiabetics can trek safely with proper planning and medical clearance
Type 2 diabetics can safely trek if their condition is well-controlled, with proper medical clearance and precautions including blood sugar monitoring, appropr…
HighWeight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clinical Proof Still Pending
GLP-1 receptor agonists like semaglutida and tirzepatida, developed for diabetes and obesity, show unexpected promise in reducing alcohol cravings. Clinical tr…
MediumGene Therapy's Promise Meets Healthcare Reality in Sickle Cell Treatment Rollout
FDA-approved gene therapies offer potential cure for sickle cell disease, yet only 164 patients have received treatment despite 100,000+ living with the condit…
HighThird-largest Ebola outbreak spreads across DRC and Uganda as response races virus
A major Ebola outbreak in the Democratic Republic of Congo and Uganda is now the third largest in history, with health officials warning of rapid spread and ca…
HighGPR75 receptor emerges as promising obesity target in genetic and animal studies
Researchers identify GPR75, a lipid-signaling receptor, as a potential therapeutic target for obesity and metabolic syndrome. Genetic studies and animal models…
HighEbola outbreak in Congo complicated by community distrust, attacks on health workers
A rare Bundibugyo Ebola outbreak in eastern Congo nears 1,000 suspected cases while healthcare workers face violent attacks from residents who distrust disease…
HighStudy finds 70-85% of atypical Alzheimer's patients ineligible for new treatments
A study finds 70-85% of atypical Alzheimer's patients don't qualify for newer anti-amyloid therapies, primarily due to cognitive screening test criteria that m…
HighCongo escalates Ebola response as WHO raises risk level amid resource crisis
WHO upgraded Congo's Ebola risk to 'very high' as the Bundibugyo virus outbreak spreads rapidly with 750 suspected cases. Authorities banned large gatherings w…
HighGeorgia Hospitals Test 'Game-Changer' Pancreatic Cancer Drug in Breakthrough Trial
Georgia hospitals are testing a new targeted pancreatic cancer drug that nearly doubles survival rates in clinical trials, marking a significant advancement in…
HighNCCN Expands Cancer Care Guidelines to Philippines Through Global Collaboration
The National Comprehensive Cancer Network is collaborating with Philippine medical organizations to develop localized cancer treatment guidelines covering 11 d…
HighContext Matters: Why Vaccinated People Appear Overrepresented in COVID Hospital Data
Expert analysis shows vaccinated people appear overrepresented in COVID hospitalizations only because they vastly outnumber unvaccinated people; unvaccinated i…
HighHantavirus outbreak on cruise ship highlights rare but deadly threat with no cure
A hantavirus outbreak aboard an Atlantic cruise ship killed three people with suspected cases in five others. The rare rodent-borne virus has no vaccine or tre…
High18 Americans Quarantined After Hantavirus Outbreak on Expedition Cruise Ship
18 Americans from a cruise ship are quarantined at specialized US facilities after a hantavirus outbreak killed 3 people. The Andes virus strain detected can r…
HighOzempic and Cancer: Separating Hype From Evidence in GLP-1 Research
Medical experts clarify emerging research on GLP-1 drugs like Ozempic for cancer prevention and treatment, cautioning against misinterpreting preliminary findi…
MediumS.C. researchers test smoking drug as potential vaping cessation treatment
MUSC researchers are studying whether Varenicline, an FDA-approved smoking cessation drug, can help adults quit vaping through a $3 million federally-funded tr…
HighBlood pressure drug telmisartan shown to enhance cancer therapy effectiveness
Dartmouth researchers found that telmisartan, a common blood pressure medication, significantly enhances the cancer-fighting effectiveness of PARP inhibitor ol…
HighWHO launches treatment trial for deadly Bundibugyo Ebola outbreak in DR Congo
WHO announces first patient enrolled in trial testing antiviral treatments for Bundibugyo Ebola outbreak in DR Congo, which has killed 438 of 1,406 confirmed c…
HighBundibugyo Ebola Strain Declared Global Health Emergency With No Vaccine
WHO declared the Ebola outbreak in DR Congo and Uganda a global health emergency, with the Bundibugyo strain having no approved vaccine or specific treatment a…
HighCancer Experts Warn: Don't Ignore Symptoms Lasting Over 2 Weeks
Cancer specialists urge people to seek medical evaluation for symptoms persisting beyond two weeks, emphasizing that early detection significantly improves sur…
HighEli Lilly's Triple-Action Diabetes Drug Shows Major Weight Loss and Blood Sugar Benefits
Eli Lilly's retatrutide, a next-generation obesity and diabetes treatment, demonstrates significant reductions in blood sugar, body weight, and sleep apnea in…
HighMob Burns Congo Ebola Center as Rare Strain Spreads
A crowd stormed a hospital in Bunia, DRC and burned an isolation ward while demanding the body of a suspected Ebola victim, hampering response to a rare Bundib…
HighSilver Diamine Fluoride Halts Cavities in Baby Teeth Without Drilling, Major U.S. Trial Finds
A major U.S. Phase III trial of 830 children under 6 found silver diamine fluoride stopped decay in over half of treated baby teeth, supporting possible FDA ap…
HighBundibugyo Ebola outbreak reaches 1,000 deaths in 67 days, faster than West Africa epidemic
A Bundibugyo Ebola outbreak in the DRC has killed over 1,000 people in 67 days—twice as fast as the 2014 West Africa epidemic. No licensed vaccine or treatment…
HighAI Model Predicts Cancer Survival Odds From Face Photos, Though Clinical Use Remains Uncertain
Researchers developed an AI tool that predicts cancer patients' survival chances from a single face photo, trained on 40M facial images and 30K+ cancer patient…
HighFourth Covid dose decision delayed as booster effectiveness data remains incomplete
US health officials say there's insufficient data to recommend fourth COVID-19 doses despite CDC findings showing booster effectiveness wanes after 4-5 months.…
HighAI Model Outperforms Doctors at Measuring Mesothelioma Tumors, Improving Treatment Decisions
Netherlands Cancer Institute researchers developed ARTIMES, an AI model that more accurately measures pleural mesothelioma tumors than current medical standard…
HighFDA Approves Moderna's mRNA Flu Vaccine After Regulatory Reversal
The FDA approved Moderna's mFLUSIVA, the first mRNA-based seasonal flu vaccine, for adults 50+, marking a milestone despite earlier regulatory pushback and cri…
HighGranada researchers develop breakthrough treatment for rare pediatric mitochondrial disease
University of Granada researchers have developed a pioneering treatment for primary coenzyme Q deficiency, a rare mitochondrial disease, with dramatic clinical…
HighFDA Grants Early Access to Daraxonrasib for Pancreatic Cancer
The FDA has granted early access to daraxonrasib, a promising pancreatic cancer treatment from Revolution Medicines, expanding patient access to a drug showing…
HighHantavirus outbreak kills 3 aboard luxury cruise ship off Cape Verde
A suspected hantavirus outbreak aboard a luxury cruise ship in the Atlantic has killed three people with five additional suspected cases. The rare rodent-borne…
HighWhy vaccinated people appear overrepresented in COVID hospitals
Expert analysis shows vaccinated people appear overrepresented in COVID hospitals only because they vastly outnumber unvaccinated people; unvaccinated remain a…
HighKalinga records 415 TB cases in first five months of 2026; officials urge early testing
Kalinga's health office recorded 415 tuberculosis cases from January to May 2026, with officials urging early testing and treatment completion to prevent disea…
HighVir, GSK advance COVID-19 antibody treatment into Phase 3 trial
Vir Biotechnology and GlaxoSmithKline have begun Phase 3 clinical trials for VIR-7831, an experimental antibody-based COVID-19 treatment targeting hospitalized…
HighNovo Nordisk set to launch Ozempic in India this month, racing generics
Danish drugmaker Novo Nordisk is launching its blockbuster diabetes drug Ozempic in India this December to capture share of the rapidly growing weight-loss tre…
HighDR Congo Ebola Cases Pass 10,000 as Bundibugyo Vaccine Trial Begins in Bunia
Confirmed Ebola cases in DR Congo have passed 10,060, with 4,887 deaths, as authorities and partners intensify containment and a Bundibugyo vaccine trial begin…
HighWHO endorses GLP-1 weight-loss drugs, issues first clinical guidance amid access concerns
The WHO released its first guidance on GLP-1 therapies for obesity treatment, recognizing it as a chronic disease requiring long-term integrated care. The cond…
HighDRC Ebola outbreak surpasses 4,000 cases as spread accelerates
DR Congo's Ebola outbreak has reached 4,053 confirmed cases with 1,850 deaths. Medical organizations warn the epidemic is spreading at an unprecedented pace wi…
HighAberdeenshire schoolgirl Sophia Wilson becomes first in UK to receive breakthrough leukaemia drug
Sophia Wilson, 10, from Aberdeenshire, became the first child in the UK to receive the unlicensed leukaemia drug Revumenib, sourced by Royal Aberdeen Children'…
MediumFDA Approves Alzheimer's Drug Amid Expert Skepticism Over Trial Data
The FDA approved aducanumab (Aduhelm) for early-stage Alzheimer's treatment via accelerated pathway, marking the first disease-modifying therapy since 2003, th…
HighPakistani hospital's reused syringes infect 331 children with HIV despite reform promises
BBC investigation reveals 331 children in Pakistan tested HIV-positive after a hospital reused syringes and violated basic hygiene protocols, with unsafe pract…
HighCongo Ebola outbreak escalates to 'very high' risk as cases surge amid resource gaps
WHO escalates Congo's Ebola outbreak risk to 'very high' with 82 confirmed cases and 750 suspected cases. Authorities ban funeral wakes and large gatherings as…
HighSFU researchers accelerate antiviral drug discovery with scalable synthesis method
Simon Fraser University chemists developed a method to create large libraries of antiviral compounds 10-100 times faster, potentially accelerating treatment di…
HighEmergency departments trial acupuncture alongside standard pain care
RMIT University and Northern Health are studying how acupuncture can be integrated into emergency care for acute pain management alongside standard treatments,…
MediumUS obesity rates show first decline in a decade, fueled by weight-loss drugs
US obesity rates appear to be declining for the first time in over a decade, potentially driven by increased use of GLP-1 weight-loss drugs like Ozempic and We…
MediumFamily Gains 'Glimmer of Hope' as Toddler Heads to New York for Experimental Neuroblastoma Vaccine Trial
Three-year-old Teddy Sloman from Pontypool, Wales, is travelling to New York for an experimental neuroblastoma vaccine trial after scans showed no active disea…
MediumIreland's cancer trials lag behind peers; CEO pushes to double patient access
Cancer Trials Ireland aims to double patient participation in clinical trials from 2.7% to 6%, currently operating 137 trials versus Denmark's 280 with similar…
HighGenomic Test Could Help Doctors Decide Which High-Risk Prostate Cancer Patients Need Abiraterone
UCL researchers presenting STAMPEDE trial data in Madrid found Decipher genomic scores predicted which high-risk prostate cancer patients benefit most from add…
MediumDaraxonrasib Doubles Survival in Advanced Pancreatic Cancer, Offering Rare Hope
A new oral drug called daraxonrasib nearly doubled survival time in advanced pancreatic cancer patients, extending median survival from 6.7 to 13.2 months by t…
HighBrazil Gets New Blood Test for Early Alzheimer's Detection
Brazilian laboratory Dasa launches a new blood test for detecting Alzheimer's disease by identifying amyloid plaques, similar to FDA-approved methods, enabling…
High